bisbenzimidazole has been researched along with Atherogenesis in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Epps, JS | 1 |
| Chew, DW | 1 |
| Vorp, DA | 1 |
1 other study available for bisbenzimidazole and Atherogenesis
| Article | Year |
|---|---|
Effects of cyclic flexure on endothelial permeability and apoptosis in arterial segments perfused ex vivo.
Topics: Albumins; Animals; Apoptosis; Atherosclerosis; Biomarkers; Bisbenzimidazole; Cell Nucleus; Coloring | 2009 |